Sharaf et al. (2022) [13] described a 71-year-old woman who developed vitiligo after 20 days of ribociclib and aromatase inhibitor treatment, with persistent depigmentation despite corticosteroids [9]. Here, CYP19A1 is linked to vitiligo.